David W Hein

33PUBLICATIONS
41CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Haematological tumoursCancer diagnosisNanomedicineEmpirical software engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 01, 2026
Clinical Function Assignment of NAT2 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.

|May 04, 2026
Impact of N-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine.

|Feb 28, 2026
Impact of the University of Louisville Cancer Education Program.

LaCreis R Kidd, Luz Huntington-Moskos, David W Hein

|Dec 23, 2025
PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.

Georgia Papanikolaou, Estella S Poloni, José A G Agúndez

|Sep 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Michael T Eadon, David W Hein, Michael A Andersen

|Aug 30, 2025
Report on the 2024 international phase II/N-acetyltransferase workshop.

David W Hein

Pageof 6

Frequent Collaborators

3 joint publications

Mariam R Habil

3 joint publications

José A G Agúndez

3 joint publications

Michelle Whirl-Carrillo

3 joint publications

Andrea Gaedigk